Other Publication Details
Mandatory Fields
Reviews
Joyce, KM,McInerney, NM,Joyce, CW,Jones, DM,Hussey, AJ,Donnellan, P,Kerin, MJ,Kelly, JL,Regan, PJ
2015
March
A review of sentinel lymph node biopsy for thin melanoma
Published
1
Optional Fields
Melanoma Thin melanoma Sentinel node Sentinel node biopsy AMERICAN JOINT COMMITTEE PRIMARY CUTANEOUS MELANOMA FOLLOW-UP MALIGNANT-MELANOMA PROGNOSTIC VALUE MITOTIC RATE II MELANOMA STAGE-I POSITIVITY GUIDELINES
Although there is a lack of established survival benefit of sentinel lymph node biopsy (SLNB), this technique has been increasingly applied in the staging of patients with thin (a parts per thousand currency sign1.00 mm) melanoma (T1Nx), without clear supportive evidence.We review the guidelines and available literature on the indications and rationale for performing SLNB in thin melanoma.As a consequence of the paucity of evidence of SLNB in thin melanoma, there is considerable variability in the guidelines. It is difficult to define clinicopathologic factors that reliably predict the presence of nodal metastasis. SLNB does not yet inform management in thin melanoma to improve survival outcome.Based on available evidence, high risk patients with melanomas between 0.75 and 1.00 mm may be appropriate candidates to be considered for SLN biopsy after discussing the likelihood of finding evidence of nodal progression, the risks of sentinel node biopsy, and the lack of proven survival benefit from any form of surgical nodal staging.
119
123
10.1007/s11845-014-1221-1
Grant Details
Publication Themes